Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

N/ATerminatedNCT01357629

Affiris AG11 enrolled

Overview

This study examines the long term Safety Follow-up of first patients vaccinated with AD02.

Patients who have received AD02 during AFF002 and AFF004A will be observed.

Study Type

OBSERVATIONAL

Enrollment

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * participation in AFF002 and AFF004A Exclusion Criteria: * no vaccination with AD02

Studienzentrum der PROSENEX Ambulatoriumsbetriebs GmbH

Vienna, State of Vienna, Austria

Univ. Klinik für Psychiatire und Psychotherapie

Vienna, Austria

Safety

collection and evaluation of AEs, SAEs

Time frame: up to 2 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.